Unlock AI-driven, actionable R&D insights for your next breakthrough.

Aldehyde Terminated Polyethylene Glycol: Synthesis, Structural Optimization, And Advanced Bioconjugation Applications

MAR 25, 202655 MINS READ

Want An AI Powered Material Expert?
Here's PatSnap Eureka Materials!
Aldehyde terminated polyethylene glycol (PEG-aldehyde) represents a critical class of reactive polymer derivatives extensively employed in bioconjugation, drug delivery, and hydrogel formation. This functionalized polyethylene glycol variant features terminal aldehyde groups that enable selective conjugation with amine-, hydrazide-, and aminooxy-containing biomolecules through Schiff base formation under mild aqueous conditions 1. The aldehyde functionality provides orthogonal reactivity compared to conventional PEG derivatives, offering enhanced control over conjugation stoichiometry and site-specificity in protein PEGylation, peptide modification, and tissue engineering scaffold design 35. Recent advances in synthesis methodologies have achieved aldehyde-terminated PEG derivatives with molecular weights ranging from 2 kDa to 50 kDa, terminal substitution rates exceeding 95%, and aldehyde content purity suitable for pharmaceutical-grade applications 916.
Want to know more material grades? Try PatSnap Eureka Material.

Molecular Architecture And Structural Characteristics Of Aldehyde Terminated Polyethylene Glycol

Aldehyde terminated polyethylene glycol comprises a hydrophilic poly(ethylene oxide) backbone with the general structure Z—(CH₂CH₂O)ₙ—CH₂CH₂—, where n typically ranges from 10 to 4000 repeating units, corresponding to molecular weights between 500 Da and 100,000 Da 68. The terminal aldehyde functionality (—CHO) can be introduced through various chemical linkages including ether bonds, amide bonds, urethane bonds, or ester bonds connecting the aldehyde moiety to the PEG backbone 12. The choice of linkage chemistry critically influences hydrolytic stability: ether and amide linkages exhibit superior resistance to hydrolysis compared to ester linkages, with half-lives exceeding 6 months in pH 7.4 phosphate buffer at 37°C 2.

Multi-arm star architectures represent an important structural variant, with 4-arm, 6-arm, and 8-arm configurations commercially available 12. Eight-arm benzaldehyde-terminated PEG with molecular weights of 5,000–20,000 Da demonstrates optimal gelation kinetics when combined with polyamino crosslinkers, achieving gel points within 10–30 seconds at 10–20% (w/v) polymer concentrations 1. The aldehyde group type significantly impacts reactivity: aromatic aldehydes (benzaldehyde derivatives) exhibit slower but more selective reactivity toward primary amines (rate constant k ≈ 10² M⁻¹s⁻¹ at pH 7.4), while aliphatic aldehydes such as propionaldehyde-terminated PEG show 3–5 fold higher reactivity but reduced selectivity 12.

End-capping of the non-reactive terminus with methoxy (mPEG), ethoxy, or benzyloxy groups minimizes non-specific interactions and protein adsorption 6812. Methoxy-terminated aldehyde PEG (mPEG-aldehyde) with molecular weights of 5 kDa, 10 kDa, 20 kDa, and 40 kDa are preferred for therapeutic protein conjugation, providing optimal pharmacokinetic profiles with circulation half-life extensions of 5–20 fold compared to unmodified proteins 57.

The spatial distribution of aldehyde groups in multi-arm architectures influences crosslinking density and mechanical properties of resulting hydrogels. Eight-arm PEG-benzaldehyde with arm lengths of 625–2,500 Da per arm (total MW 5–20 kDa) provides aldehyde group densities of 1.6–6.4 mmol/g, enabling tunable crosslinking densities when reacted with tetra-functional or octa-functional amine crosslinkers 12.

Synthesis Routes And Process Optimization For Aldehyde Terminated Polyethylene Glycol

Oxidative Cleavage Of Vicinal Diols

A widely adopted synthesis route involves oxidative cleavage of PEG-vicinal diols using sodium periodate (NaIO₄) as the oxidizing agent 4. The process begins with protection of a terminal hydroxyl group of PEG using a ketal protecting group, followed by base-catalyzed substitution with phenyl sulfonate-activated ketal compounds in aprotic solvents such as tetrahydrofuran (THF) or dimethylformamide (DMF) at 60–80°C for 12–24 hours 4. Deprotection under acidic conditions (0.1–1.0 M HCl, 25°C, 2–6 hours) yields PEG-vicinal diol intermediates, which undergo selective oxidative cleavage with 1.1–1.5 molar equivalents of NaIO₄ in water or water/methanol mixtures at 0–25°C for 1–4 hours, generating the terminal aldehyde with yields of 75–92% 4.

Critical process parameters include maintaining pH 4–6 during oxidation to minimize over-oxidation to carboxylic acids, and immediate quenching with ethylene glycol (2–5 equivalents) to consume excess periodate 4. Purification by dialysis (molecular weight cut-off 1–3 kDa) against deionized water for 48–72 hours, followed by lyophilization, affords aldehyde-terminated PEG with residual periodate levels below 10 ppm and aldehyde substitution rates of 88–96% as determined by ¹H NMR integration of aldehyde proton signals at δ 9.5–9.8 ppm 49.

Direct Functionalization Via Acetal Intermediates

An alternative high-yield method employs small-molecule cyclic acetal derivatives as aldehyde precursors 16. Linear or multi-arm PEG-hydroxyl derivatives react with 2,2-dimethyl-1,3-dioxolane-4-methanol or similar cyclic acetals in the presence of strong bases (sodium hydride, potassium tert-butoxide, 1.2–2.0 equivalents) in anhydrous THF or toluene at 50–80°C for 8–16 hours under inert atmosphere 16. The resulting PEG-acetal intermediates undergo acid-catalyzed deprotection (0.5–2.0 M HCl in methanol or aqueous dioxane, 25–40°C, 2–6 hours) to liberate terminal aldehydes with overall yields of 82–94% and terminal substitution rates exceeding 95% 16.

This method offers advantages including scalability to multi-kilogram batches, reduced formation of carboxylic acid by-products (typically <2% by HPLC), and compatibility with multi-arm PEG architectures 16. Purification involves neutralization with solid sodium bicarbonate, filtration, concentration under reduced pressure (20–40 mbar, 40–50°C), and precipitation into cold diethyl ether or isopropanol, yielding products with aldehyde content of 95–98% purity as determined by derivatization with 2,4-dinitrophenylhydrazine followed by UV-Vis spectroscopy at 358 nm 16.

Aromatic Aldehyde Conjugation

For benzaldehyde-terminated PEG derivatives, direct conjugation of 4-formylbenzoic acid or 4-carboxybenzaldehyde to PEG-amine or PEG-hydroxyl precursors via amide or ester linkages provides an efficient route 12. PEG-amine (1.0 equivalent) reacts with 4-formylbenzoic acid (1.2–1.5 equivalents) in the presence of coupling reagents such as N,N'-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in dichloromethane at 25°C for 12–24 hours, affording benzaldehyde-terminated PEG with amide linkages exhibiting hydrolytic half-lives exceeding 12 months at pH 7.4 and 37°C 12.

Eight-arm PEG-amine (MW 10 kDa) functionalized with benzaldehyde groups via this route demonstrates aldehyde substitution of 7.6–7.9 groups per molecule (95–99% substitution) and forms stable hydrogels when mixed with ε-polylysine or poly-L-lysine (MW 15–30 kDa) at molar ratios of aldehyde:amine of 0.8:1 to 1.2:1 in pH 7.4 phosphate buffer 12. Gelation occurs within 15–45 seconds at 15% (w/v) total polymer concentration, with resulting hydrogels exhibiting compressive moduli of 5–25 kPa and swelling ratios of 15–30 in aqueous media 12.

Process Control And Quality Assurance

Key analytical methods for characterizing aldehyde-terminated PEG include:

  • ¹H NMR spectroscopy: Aldehyde proton signals at δ 9.5–9.8 ppm enable quantification of terminal substitution rates; integration relative to PEG backbone protons (δ 3.6 ppm) provides substitution percentages with ±2% accuracy 916.
  • MALDI-TOF mass spectrometry: Confirms molecular weight distributions and absence of high-molecular-weight aggregates; polydispersity indices (PDI) should remain below 1.10 for pharmaceutical applications 916.
  • Aldehyde content assay: Derivatization with 2,4-dinitrophenylhydrazine (DNPH) followed by UV-Vis quantification at 358 nm or HPLC analysis provides aldehyde content with ±3% precision 911.
  • Residual catalyst analysis: ICP-MS or ICP-OES quantification of sodium, potassium, or periodate residues; specifications typically require <50 ppm total metal content and <10 ppm periodate for biomedical applications 916.

Stability testing under accelerated conditions (40°C, 75% relative humidity, 6 months) demonstrates that aldehyde-terminated PEG stored as lyophilized powders under inert atmosphere retains >92% aldehyde functionality, while aqueous solutions at pH 4–6 and 4°C maintain >85% activity over 12 months 916.

Physicochemical Properties And Performance Characteristics

Molecular Weight And Polydispersity

Aldehyde terminated polyethylene glycol derivatives are commercially available with nominal molecular weights ranging from 250 Da to 50,000 Da, with preferred ranges of 2,000–30,000 Da for bioconjugation applications 6812. Polydispersity indices (Mw/Mn) typically fall between 1.02 and 1.08 for products synthesized via anionic ring-opening polymerization of ethylene oxide, ensuring narrow molecular weight distributions critical for reproducible conjugation stoichiometry 916.

Higher molecular weight PEG-aldehydes (20–50 kDa) exhibit enhanced circulation half-lives when conjugated to therapeutic proteins, with 40 kDa mPEG-aldehyde conjugates of granulocyte colony-stimulating factor (G-CSF) demonstrating terminal half-lives of 18–24 hours compared to 3–4 hours for unmodified G-CSF 57. However, conjugation efficiency decreases with increasing PEG molecular weight due to steric hindrance, with optimal conjugation yields (70–85%) observed for 5–20 kDa PEG-aldehydes 57.

Solubility And Solution Behavior

Aldehyde-terminated PEG exhibits excellent solubility in water (>500 g/L at 25°C for MW <20 kDa), as well as in polar organic solvents including methanol, ethanol, acetonitrile, dichloromethane, chloroform, and dimethyl sulfoxide 68. Aqueous solutions demonstrate Newtonian flow behavior at concentrations below 30% (w/v), with dynamic viscosities ranging from 2–15 mPa·s for 10% (w/v) solutions of 5–20 kDa PEG-aldehyde at 25°C 12.

The aldehyde functionality does not significantly alter the hydration shell structure of PEG compared to hydroxyl-terminated analogs, with each ethylene oxide unit coordinating approximately 2–3 water molecules as determined by differential scanning calorimetry (DSC) analysis of freezing-bound water 12. Cloud points in aqueous solutions remain above 100°C for PEG-aldehydes with MW <10 kDa, indicating excellent thermal stability and absence of lower critical solution temperature (LCST) behavior under physiological conditions 68.

Reactivity And Conjugation Kinetics

The aldehyde group undergoes nucleophilic addition reactions with primary amines, hydrazides, and aminooxy compounds, forming Schiff base (imine) linkages 125. Reaction kinetics are pH-dependent, with optimal rates observed at pH 5–7 for amine conjugation and pH 4–6 for hydrazide/aminooxy conjugation 12. Second-order rate constants for benzaldehyde-terminated PEG reacting with lysine ε-amino groups are approximately 80–150 M⁻¹s⁻¹ at pH 7.4 and 25°C, while aliphatic aldehyde-terminated PEG exhibits rate constants of 300–600 M⁻¹s⁻¹ under identical conditions 12.

Schiff base linkages formed with aromatic aldehydes demonstrate enhanced stability compared to aliphatic analogs, with hydrolysis half-lives of 48–96 hours at pH 7.4 and 37°C for benzaldehyde-derived imines versus 8–24 hours for propionaldehyde-derived imines 12. Reductive amination using sodium cyanoborohydride (NaBH₃CN, 5–20 mM) or sodium triacetoxyborohydride (NaBH(OAc)₃, 10–50 mM) converts Schiff bases to stable secondary amines, increasing hydrolytic stability to >6 months at physiological pH 57.

Conjugation efficiency to model proteins (bovine serum albumin, lysozyme) ranges from 65–90% for 5 kDa mPEG-aldehyde at 5–10 molar equivalents of PEG per protein, with site-specificity favoring N-terminal α-amino groups and surface-exposed lysine residues 57. Size-exclusion chromatography (SEC) and SDS-PAGE analysis confirm formation of mono-, di-, and tri-PEGylated species, with molecular weight increases of 5–15 kDa per PEG chain attached 57.

Thermal And Chemical Stability

Thermogravimetric analysis (TGA) of aldehyde-terminated PEG reveals onset of thermal decomposition at 280–320°C, with 5% weight loss temperatures (Td5%) of 290–310°C under nitrogen atmosphere 916. Differential scanning calorimetry (DSC) shows melting transitions (Tm) at 45–65°C for PEG-aldehydes with MW 2–10 kDa, consistent with semi-crystalline morphology 916. Glass transition temperatures (Tg) range from -65°C to -55°C, indicating excellent low-temperature flexibility 916.

Chemical stability studies demonstrate that aldehyde-terminated PEG is stable to non-oxidizing acids (pH 2–6), bases (pH 8–11), and common organic solvents (alcohols, ketones, esters, ethers) at 25°C for >12 months 916. However, exposure to strong oxidizing agents (hydrogen peroxide >1%, peracetic acid, permanganate) results in oxidation of aldehyde to carboxylic acid, with conversion rates of 10–30% after 24 hours at 25°C 916. Storage under inert atmosphere (nitrogen or argon) and exclusion of light minimizes oxidative degradation, with aldehyde content remaining >95% after 24 months at -20°C 916.

Applications Of Aldehyde Terminated Polyethylene Glycol In

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
SHANGHAI RUINING BIOTECHNOLOGY CO. LTDRadiation protection materials, tissue engineering scaffolds, and in-situ crosslinking medical applications requiring rapid gelation under physiological conditions.Eight-arm PEG-Benzaldehyde Medical HydrogelForms stable hydrogels within 15-45 seconds via Schiff base formation with polylysine, achieving compressive moduli of 5-25 kPa and long-term stability in aqueous solution through hydrolysis-resistant amide/ether linkages.
XIAMEN SINOPEG BIOTECH CO. LTDBioconjugation applications, drug delivery systems, protein PEGylation, and hydrogel formation requiring high terminal functionality and pharmaceutical-grade purity.Multi-arm Star PEG-Aldehyde DerivativesAchieves terminal aldehyde substitution rates exceeding 95%, high purity (95-98% aldehyde content), and yields of 82-94% through optimized acetal intermediate synthesis with reduced carboxylic acid by-products (<2%).
F.HOFFMANN-LA ROCHE AGTherapeutic protein modification, PEGylation of biologics including G-CSF and antibody fragments for enhanced pharmacokinetic profiles and reduced immunogenicity.mPEG-Aldehyde Protein ConjugatesProvides selective conjugation with amine-containing biomolecules through Schiff base formation, achieving 5-20 fold circulation half-life extensions for therapeutic proteins with conjugation yields of 70-85%.
DOW GLOBAL TECHNOLOGIES INCLong-circulating drug conjugates, sustained-release pharmaceutical formulations, and surface modification applications requiring extended polymer chain lengths.High Molecular Weight mPEG-Aldehyde (20-60 kDa)Oxidative cleavage synthesis via sodium periodate achieves 75-92% yields with aldehyde substitution rates of 88-96%, residual periodate <10 ppm, and molecular weights up to 60,000 Daltons.
NEKTAR THERAPEUTICSSolid-phase synthesis supports, chromatographic resins, enzyme immobilization substrates, and versatile bioconjugation platforms for peptide and oligonucleotide modification.Multi-armed PEG-Aldehyde PolymersLinear and branched architectures with molecular weights 2-50 kDa, terminal substitution >95%, and compatibility with multiple functional groups (hydroxy, amino, aldehyde) for orthogonal bioconjugation strategies.
Reference
  • Medical hydrogel having radiation protection function
    PatentInactiveUS20210213182A1
    View detail
  • Medical hydrogel
    PatentInactiveUS20210162092A1
    View detail
  • Method for preparation of polyethylene glycol aldehyde derivatives
    PatentInactiveUS6465694B1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png